Accueil / Communiqués (page 3)

Communiqués

Global ATP Assay Market Forecasts, 2019-2024 – Promising Growth Prospects in Emerging Markets – ResearchAndMarkets.com

Wednesday, November 6th 2019 at 3:44pm UTC DUBLIN–(BUSINESS WIRE)– The « ATP Assay Market by Product (Consumables (Kit, Reagent, Microplate), Instrument (Luminometer, Spectrophotometer)), Application (Contamination Test, Disease Test), End User (Pharmaceutical & Biotechnology Company, F&B), Region – Global Forecast to 2024 » report has been added to ResearchAndMarkets.com’s offering. The ATP assays …

Plus »

Outlook on the $1.3Bn+ Starter Culture Market, 2019-2025 – Multi-Strain Mixed Compositions to Witness Robust Growth – ResearchAndMarkets.com

Wednesday, November 6th 2019 at 8:27pm UTC DUBLIN–(BUSINESS WIRE)– The « Starter Culture Market by Microorganism (Bacteria, Yeasts, Molds), Application (Dairy & Dairy-based Products, Meat & Seafood), Composition (Multi-strain Mix, Single Strain, Multi-strain), Form, and Region – Global Forecast to 2025 » report has been added to ResearchAndMarkets.com’s offering. The global starter …

Plus »

ProtoKinetix AAGP® Operational Update

Wednesday, November 6th 2019 at 2:00pm UTC MARIETTA, Ohio–(BUSINESS WIRE)– ProtoKinetix, Incorporated (www.protokinetix.com) (the « Company » or « ProtoKinetix ») (OTCQB:PKTX) is pleased to provide the following updates regarding upcoming news in key areas. Current projects updates are expected from the following:  1. Dry Eye Disease (DED) – ProtoKinetix is expecting closure of …

Plus »

Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor – Global Pipeline Insight Report 2019 – ResearchAndMarkets.com

Wednesday, November 6th 2019 at 1:26pm UTC DUBLIN–(BUSINESS WIRE)– The « Human Epidermal Growth Factor Receptor 4 (HER-4 or ErbB-4) Inhibitor – Pipeline Insight, 2019 » drug pipelines has been added to ResearchAndMarkets.com’s offering. This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Human Epidermal …

Plus »

Puma Biotechnology Reports Third Quarter 2019 Financial Results

Wednesday, November 6th 2019 at 9:07pm UTC LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2019. Unless otherwise stated, all comparisons are for the third quarter 2019 compared to the third quarter 2018. Product revenue, net consists …

Plus »

Takeda to Highlight Expanded Portfolio of Products Across Oncology and Hematology at 61st American Society of Hematology (ASH) Annual Meeting

Wednesday, November 6th 2019 at 5:00pm UTC – Company Leadership to Present 20 Abstracts in Oncology and Nine in Hematology Throughout Conference, Showcasing Takeda’s Unique Expertise in Blood Cancers and Bleeding Disorders – CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) today announced that it will …

Plus »

Baxter and Ayogo Launch CKD&Me Patient Empowering Digital Education Tool at Kidney Week 2019

Wednesday, November 6th 2019 at 1:30pm UTC CKD&Me fills the gap in pre-dialysis education by providing objective kidney care content U.S. pilot of CKD&Me supplements patient education in several U.S. nephrology practices CKD&Me tailors its content for individual patient needs, covering physiology, treatment options, and lifestyle factors in a manner …

Plus »

GlycoMimetics to Present Further Analysis of Data From Phase 1/2 AML Trial of Uproleselan at 61st ASH Meeting

Wednesday, November 6th 2019 at 3:03pm UTC Latest analysis of clinical data on novel therapeutic candidate will be shared, showing that uproleselan can augment deep clinical responses and prolong overall survival in high risk patients with acute myeloid leukemia (AML) Additional presentations highlight E-selectin as a major extrinsic contributor to …

Plus »

The Medicines Company to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 2019

Wednesday, November 6th 2019 at 9:30pm UTC ORION-10 presentation on November 16 and ORION-9 presentation on November 18 Company also to sponsor educational sessions throughout AHA annual meeting Company to host investor conference call and webcast on Monday, November 18, 12:00 pm EST, to discuss results of studies PARSIPPANY, N.J.–(BUSINESS …

Plus »

Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019

Wednesday, November 6th 2019 at 9:05pm UTC VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that it will release its third quarter 2019 financial results on Thursday, November 14, 2019, after the market closes. Aurinia’s management team will host a conference call …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.